Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
boston top stories
cancer
4
×
life sciences
national blog main
national top stories
roche
4
×
san francisco blog main
san francisco top stories
amgen
cancer drugs
clinical trials
indiana blog main
indiana top stories
national
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
aprea therapeutics
arimoclomol
arnold levine
array biopharma
astrazeneca
avapritinib
baker brothers
barcelona
beacon
biotech ipos
bladder
blueprint medicines
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
What
cancer
4
×
drug
ipo
medicines
address
annual
approval
approves
ash
barcelona
blood
blueprint
broader
carries
certain
clinical
company
conference
december's
designed
despite
detect
developing
esmo
european
family
fda
files
firms
genetic
grail
hardest
hit
hottest
hunters
intended
investors
join
kras
latest
Language
unset
4
×
Current search:
roche
×
cancer
×
" boston blog main "
×
cancer
×
unset
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More